An experimental vaccine has been found to prevent recurrence of melanoma. Scientists hope it won’t be the last.
A new, experimental vaccine could become the first of its kind to treat cancer.
Nina Agrawal, a health reporter for The New York Times, explains how a century-old idea is finally becoming a reality and where this breakthrough could lead next.
Guest: Nina Agrawal, a health reporter for The New York Times.
Background reading:
- The first-of-its-kind vaccine has ushered in new hope for cancer patients.
- Drug makers reported that the cancer vaccine cut the risk of melanoma recurrence.
Photo: Brendan Mcdermid/Reuters
For more information on today’s episode, visit nytimes.com/thedaily. Transcripts of each episode will be made available by the next workday.
For more information on today’s episode, visit nytimes.com/thedaily. Transcripts of each episode will be made available by the next workday.
Subscribe today at nytimes.com/podcasts or on Apple Podcasts, Spotify and Amazon Music. You can also subscribe via your favorite podcast app here https://www.nytimes.com/activate-access/audio?source=podcatcher. For more podcasts and narrated articles, download The New York Times app at nytimes.com/app.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Discover more from DrWeb's Domain
Subscribe to get the latest posts sent to your email.
